34.41 USD
+1.56 (+4.75%)
ChartMill assigns a Buy % Consensus number of 87% to GPCR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 77.37. This target is 124.86% above the current price.
GPCR was analyzed by 21 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about GPCR.
In the previous month the buy percentage consensus was at a similar level.
GPCR was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-07 | Guggenheim | Maintains | Buy -> Buy |
| 2025-08-07 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-23 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-06-23 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-02 | Citigroup | Initiate | Buy |
| 2025-04-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-28 | Citizens Capital Markets | Maintains | Market Outperform -> Market Outperform |
| 2025-02-28 | William Blair | Initiate | Outperform |
| 2025-01-08 | Stifel | Initiate | Buy |
| 2024-12-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-18 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-12-04 | HC Wainwright & Co. | Initiate | Buy |
| 2024-09-23 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-23 | Morgan Stanley | Initiate | Overweight |
| 2024-09-16 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-19 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-15 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-09 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-07-01 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-17 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-07 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-06-03 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-05-21 | JP Morgan | Initiate | Overweight |
| 2024-05-10 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-05-03 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
STRUCTURE THERAPEUTICS INC / GPCR FAQ
What is the average price target for STRUCTURE THERAPEUTICS INC (GPCR) stock?
21 analysts have analysed GPCR and the average price target is 77.37 USD. This implies a price increase of 124.86% is expected in the next year compared to the current price of 34.41.
Can you provide the consensus rating for STRUCTURE THERAPEUTICS INC stock?
The consensus rating for STRUCTURE THERAPEUTICS INC (GPCR) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.